ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer
A phase 2 trial of Pegfilgrastim and Darbepoetin alfa in Breast cancer, run by Amgen, completed.
Overview
ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer is a phase 2 interventional study registered as NCT00261313 by Amgen, with 80 participants recorded, started 2005-12 and reaching its primary completion in 2007-06. Interventions recorded: Neulasta, Aranesp. Conditions recorded: Breast Cancer.
Linked to the drug Darbepoetin alfa because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialDocetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Shares Darbepoetin alfa, Pegfilgrastim and the tag pipeline.
- TrialNeulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Shares Pegfilgrastim, Breast cancer (all types) and the tag pipeline.
- TrialSequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer
Shares Pegfilgrastim, Breast cancer (all types) and the tag pipeline.
- TrialRandomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer
Shares Pegfilgrastim, Breast cancer (all types) and the tag pipeline.
- TrialSix vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
Shares Pegfilgrastim, Breast cancer (all types) and the tag pipeline.
- TrialErythropoietin for Management of Anemia Caused by Chemotherapy
Shares Darbepoetin alfa and the tag pipeline.
- TrialAn Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma
Shares Amgen and the tag pipeline.
- TrialStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Shares Amgen and the tag pipeline.